Manufacturing Plants
Taj Pharma
Taj Pharmaceuticals is a global leader in the pharmaceutical industry, renowned for its commitment to producing high-quality medications that meet stringent international standards. With cutting-edge manufacturing plants spread across India, Taj Pharma has established itself as a key player in various therapeutic segments, from oncology treatments to nutraceuticals. The company’s success is driven by its state-of-the-art facilities, each tailored to produce specific types of pharmaceutical products.
Sarigam GIDC Manufacturing Plant
The Sarigam GIDC Manufacturing Plant is one of Taj Pharma’s flagship facilities, designed to produce a wide range of pharmaceutical products. Equipped with advanced technology, this plant caters to multiple product categories, ensuring high-capacity production to meet both local and international demand.
Product Categories and Capacities
- Tablets: With a monthly capacity of 120 million tablets, the Sarigam plant is capable of handling large-scale production for various therapeutic applications.
- Capsules: This facility also produces 40 million capsules per month, ensuring a steady supply of this essential dosage form.
- Dry Blended Powders / Granules: The plant has the capacity to produce 20 million units of dry blended powders and granules per month, which are used in a variety of medications.
- Effervescent Tablets: With a capacity of 20 million units per month, effervescent tablets are manufactured here for easy-to-use formulations.
- Oral Jelly: A popular dosage form for certain medications, the plant can produce up to 60 million units of oral jelly each month.
- Creams / Ointments: For topical treatments, the Sarigam plant produces 40 million units of creams and ointments per month.
- Oral Sachets: With a capacity of 3 million sachets per month, this dosage form provides an alternative for certain medications.
Injections Plant – Kalgam Village, Valsad
The Kalgam Village plant is dedicated to the production of liquid and dry powder injections, a critical area in pharmaceuticals that ensures safe and effective delivery of medications via parenteral routes.
Shift-wise Production Capacities
- Liquid Ampoule Injection: The plant can produce 2.5 lakh liquid ampoule injections per shift, ensuring a consistent supply for hospitals and clinics.
- Liquid Vial Injection: Another high-demand product, the plant produces 2.5 lakh liquid vial injections per shift.
- Dry Injection: With a capacity of 3.5 lakh dry injections per shift, this facility ensures the production of stable and effective medications.
- Small Volume Parenterals (SVP): SVPs are produced at a rate of 4.5 lakh units per shift, meeting the needs for smaller dose parenteral medications.
Vadgas, Viramgam – Ahmadabad Block Unit 1
This facility specializes in the production of general liquid injections, dry powders, lyophilized injections, and prefilled syringes, which are crucial for various therapeutic uses.
Specializations
- Liquid Injections: The plant produces large volumes of liquid injections, essential for treatments requiring immediate therapeutic effects.
- General Dry Powder: Dry powders are produced for various applications, ensuring long shelf life and stability of the medication.
- Lyophilized Injections: This advanced technology ensures the preservation of sensitive drugs through freeze-drying.
- Prefilled Syringes: For convenience and safety, prefilled syringes are produced at this unit, offering an accurate and ready-to-use dosage form.
Vadgas, Viramgam – Ahmadabad Block Unit 2 – Oncology
Unit 2 is dedicated to the production of oncology medications, focusing on cytotoxic drugs, which are vital for cancer treatment.
Cytotoxic Products
- Tablets: Specialized cytotoxic tablets are produced here for oral cancer treatments.
- Capsules: Cytotoxic capsules are also produced for oncology therapies.
- Liquid Injections: Cytotoxic liquid injections provide a potent form of chemotherapy and other cancer treatments.
- Dry Powder Injections: These are formulated to meet the specific needs of oncology treatment.
- Lyophilized Injections: The plant also produces lyophilized forms of cytotoxic medications to ensure their stability and efficacy.
Vadgas, Viramgam – Ahmadabad Unit 3 – Beta Lactam
Unit 3 is a key facility for the production of Beta Lactam antibiotics, which are essential in the treatment of bacterial infections.
Beta Lactam Products
- Tablets: Beta Lactam tablets are produced in large quantities to meet global healthcare demands.
- Capsules: Similarly, the facility produces Beta Lactam capsules for various antibiotic therapies.
- Dry Powder Injections: These are crucial for administering antibiotics in a stable, potent form.
- Dry Suspension: The plant also produces dry suspensions, which are often used in pediatric antibiotic formulations.
LVP – Large Volume Parenterals
Taj Pharma’s LVP plant is focused on producing large-volume parenteral solutions, which are critical for intravenous therapies in hospitals.
FFS Bottle Capacity
The plant has the capacity to produce 10 million FFS (Form-Fill-Seal) bottles per day, a popular packaging format for IV solutions.
Euro Cap Bottle Capacity
Additionally, the plant can produce 5 million Euro cap bottles per day, offering a high-capacity solution for IV therapies.
Vadgas, Viramgam – Ahmadabad Block Unit 5
This unit is US FDA-approved and specializes in the production of tablets and capsules, ensuring compliance with the highest international standards for pharmaceutical manufacturing.
Vadgas, Viramgam – Ahmadabad Unit 6
Unit 6 focuses on the production of nutraceuticals and food supplements, addressing the growing demand for health and wellness products.
Significance of Taj Pharma in the Pharmaceutical Industry
Taj Pharma’s extensive manufacturing capabilities have made it a global leader in the pharmaceutical industry. Its dedication to quality, innovation, and scalability ensures that it remains at the forefront of healthcare solutions, providing essential medications to millions worldwide.
Taj Pharma’s manufacturing plants represent the pinnacle of pharmaceutical production, from high-capacity tablet production to specialized oncology medications. Each facility plays a crucial role in the company’s mission to deliver high-quality, accessible medications that meet global healthcare needs. As the demand for advanced pharmaceutical solutions grows, Taj Pharma continues to expand its capabilities, ensuring a healthier future for all.
FAQs
- What is the capacity of the Sarigam GIDC Plant?
The Sarigam GIDC Plant can produce 120 million tablets, 40 million capsules, and a variety of other pharmaceutical forms per month. - What is produced at the Vadgas, Viramgam Unit 5?
This unit specializes in the production of tablets and capsules, and it is US FDA-approved. - How does Taj Pharma address oncology treatment needs?
Taj Pharma’s Unit 2 focuses on oncology, producing cytotoxic medications, including tablets, capsules, and injections, for cancer treatment. - What role does the LVP unit play in healthcare?
The LVP unit produces large-volume parenteral solutions, which are critical for intravenous therapies in hospitals. - What makes Taj Pharma’s manufacturing facilities unique?
Taj Pharma’s facilities are equipped with cutting-edge technology and meet stringent global standards, ensuring high-quality and efficient production of pharmaceuticals.